New England Peptide, Inc. and ACRI Launch New Biotech Company, Excipio Technologies, Inc. to Study Exosome Isolation

December 26, 2013 Leave a comment

New England Peptide (NEP), a Massachusetts based biotech manufacturer, and The Atlantic Cancer Research Institute (ACRI), a leading cancer research center in Atlantic Canada, have launched a new biotech company. Excipio Technologies Inc. has a mandate to commercialize the Vn96 ...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: The Atlantic Cancer Research Institute

New England Peptide, Inc. and ACRI Launch New Biotech Company, Excipio Technologies, Inc. to Study Exosome Isolation

Researchers develop a blood test to identify individuals at risk of developing Parkinson’s disease

Metabolic tagging of extracellular vesicles and development of enhanced extracellular vesicle based cancer vaccines

Extracellular vesicles from the placenta may offer major clues on the in utero development of neurobehavioral disorders

Exai Bio’s RNA- and AI-based Liquid Biopsy Platform Detects Early Stage Breast Cancer with High Accuracy, Overcoming Many Limitations of DNA-based Approaches

HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment

NVIGEN unveils groundbreaking comprehensive liquid biopsy – multimodal biomarker detection enabled by highly versatile nanoparticle capture